Aigen Investment Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-5,758
Closed -$2M – 888
2024
Q1
$2M Buy
5,758
+1,437
+33% +$545K 0.43% 48
2023
Q4
$1.98M Buy
+4,321
New +$2.13M 0.35% 57
2022
Q4
– Sell
-9,132
Closed -$4.43M – 646
2022
Q3
$4.43M Buy
+9,132
New +$4.44M 0.64% 36
2022
Q2
– Sell
-4,127
Closed -$1.8M – 620
2022
Q1
$1.8M Buy
4,127
+1,948
+89% +$815K 0.31% 88
2021
Q4
$994K Buy
+2,179
New +$964K 0.06% 424
2021
Q2
– Sell
-6,330
Closed -$2.65M – 591
2021
Q1
$2.65M Buy
+6,330
New +$2.53M 0.35% 72

Other funds holding HUM

Aigen Investment Management's HUM Position: Q2 2024 in Review

Aigen Investment Management sold out of Humana (HUM) in Q2 2024, closing a stake of 5,758 shares — an estimated $2M sold.

Aigen Investment Management first reported a position in HUM in Q1 2021 and held it in 6 quarters. The position peaked at $4.43M in Q3 2022. 981 funds tracked by Wall St. Rank hold HUM as of Q2 2024.

  • Aigen Investment Management reported no remaining Humana position as of Q2 2024 after selling out during the quarter.
  • Aigen Investment Management sold 5,758 Humana shares in Q2 2024, an estimated $2M.
  • Aigen Investment Management first reported a position in Humana in Q1 2021 and held it in 6 quarters.
  • Aigen Investment Management's Humana position peaked at $4.43M in Q3 2022.
  • 981 funds tracked by Wall St. Rank held Humana as of Q2 2024.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.